Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Myocardial imaging in dogs treated with grisorixin: relationship between /sup 201/Tl uptake and coronary blood flow

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6780860
/sup 201/Tl myocardial imaging was performed in dogs after pretreatment with grisorixin, which appeared to increase the myocardial uptake of /sup 201/Tl. This effect of grisorixin was found to be dose dependent, with an optimal dose of 60 microgram/kg. The myocardial-to-background ratio, which was 1.92 in the control dogs, rose to 4.45. The increase in the absolute myocardial uptake was demonstrated in guinea pigs that received /sup 201/Tl after similar pretreatment with grisorixin. In the animals treated with 500 microgram/kg, the uptake of /sup 201/Tl by the heart was 35% over the control value. With 60 microgram/kg grisorixin, the coronary blood flow increased from 40 to 176 ml/min 5 min after the injection. This dose, optimal for imaging, induced the maximum vasodilator effect with only a very slight concomitant increase in the left-ventricular pressure and myocardial contractility. Above 60 microgram/kg, grisorixin appeared to be a potent inotropic agent, whereas below this dose it showed only coronary vasodilator properties. Some evidence for an ionophore effect of this compound was found in dogs pretreated with 60 microgram/kg. In these the radionuclide was injected when the coronary vasodilatation had become insignificant, but a significant improvement of the M/B ratio was still evident.
Research Organization:
U. 195 INSERM, University of Clermont-Ferrand, France
OSTI ID:
6780860
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 23:4; ISSN JNMEA
Country of Publication:
United States
Language:
English